Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martin Empting

Showing results (51-60 of 80) with videos related to

Pageof 8
Sort By:
Drug Delivery and Translational Research|July 24, 2024
Nanoparticles in liposomes: a platform for increased antibiotic selectivity in multidrug resistant bacteria in respiratory tract infectionsNathalie E Fakhoury, Samar Mansour, Mohammad Abdel-Halim, et al.
Chemmedchem|November 12, 2019
Flexible Fragment Growing Boosts Potency of Quorum-Sensing Inhibitors against Pseudomonas aeruginosa VirulenceMichael Zender, Florian Witzgall, Alexander Kiefer, et al.
Organic & Biomolecular Chemistry|April 20, 2010
Towards click bioconjugations on cube-octameric silsesquioxane scaffoldsSebastian Fabritz, Dirk Heyl, Viktor Bagutski, et al.
European Journal of Medicinal Chemistry|September 14, 2021
Divergent synthesis and biological evaluation of 2-(trifluoromethyl)pyridines as virulence-attenuating inverse agonists targeting PqsRChristian Schütz, Amir Hodzic, Mostafa Hamed, et al.
Scientific Reports|August 31, 2017
Semi-synthetic vNAR libraries screened against therapeutic antibodies primarily deliver anti-idiotypic bindersDoreen Könning, Laura Rhiel, Martin Empting, et al.
Frontiers in Bioscience (Landmark Edition)|January 30, 2024
Gene Editing and Small Molecule Inhibitors of the RNA Binding Protein IGF2BP2/IMP2 Show its Potential as an Anti-Cancer Drug TargetShilpee Chanda, Konstantin Lepikhov, Charlotte Dahlem, et al.
Journal of Medicinal Chemistry|July 28, 2023
Disrupting Kaposi's Sarcoma-Associated Herpesvirus (KSHV) Latent Replication with a Small Molecule InhibitorAylin Berwanger, Saskia C Stein, Andreas M Kany, et al.
Small Methods|May 7, 2025
Native Taylor/Non-Taylor Dispersion-Mass Spectrometry (TNT-MS) Allows Rapid Protein Desalting and Multiplexed, Label-Free Ligand ScreeningJonathan Eisert, Edvaldo Vasconcelos Soares Maciel, Verena Dederer, et al.
European Journal of Medicinal Chemistry|July 23, 2024
Discovery and optimization of thiazole-based quorum sensing inhibitors as potent blockers of Pseudomonas aeruginosa pathogenicityAhmed S Abdelsamie, Mostafa M Hamed, Christian Schütz, et al.
Future Medicinal Chemistry|June 3, 2016
Discovery of the first small-molecule CsrA-RNA interaction inhibitors using biophysical screening technologiesChristine K Maurer, Martina Fruth, Martin Empting, et al.
Pageof 8

Showing results (51-60 of 80) with videos related to

Sort By:
Pageof 8
Drug Delivery and Translational Research|July 24, 2024
Nanoparticles in liposomes: a platform for increased antibiotic selectivity in multidrug resistant bacteria in respiratory tract infectionsNathalie E Fakhoury, Samar Mansour, Mohammad Abdel-Halim, et al.
Chemmedchem|November 12, 2019
Flexible Fragment Growing Boosts Potency of Quorum-Sensing Inhibitors against Pseudomonas aeruginosa VirulenceMichael Zender, Florian Witzgall, Alexander Kiefer, et al.
Organic & Biomolecular Chemistry|April 20, 2010
Towards click bioconjugations on cube-octameric silsesquioxane scaffoldsSebastian Fabritz, Dirk Heyl, Viktor Bagutski, et al.
European Journal of Medicinal Chemistry|September 14, 2021
Divergent synthesis and biological evaluation of 2-(trifluoromethyl)pyridines as virulence-attenuating inverse agonists targeting PqsRChristian Schütz, Amir Hodzic, Mostafa Hamed, et al.
Scientific Reports|August 31, 2017
Semi-synthetic vNAR libraries screened against therapeutic antibodies primarily deliver anti-idiotypic bindersDoreen Könning, Laura Rhiel, Martin Empting, et al.
Frontiers in Bioscience (Landmark Edition)|January 30, 2024
Gene Editing and Small Molecule Inhibitors of the RNA Binding Protein IGF2BP2/IMP2 Show its Potential as an Anti-Cancer Drug TargetShilpee Chanda, Konstantin Lepikhov, Charlotte Dahlem, et al.
Journal of Medicinal Chemistry|July 28, 2023
Disrupting Kaposi's Sarcoma-Associated Herpesvirus (KSHV) Latent Replication with a Small Molecule InhibitorAylin Berwanger, Saskia C Stein, Andreas M Kany, et al.
Small Methods|May 7, 2025
Native Taylor/Non-Taylor Dispersion-Mass Spectrometry (TNT-MS) Allows Rapid Protein Desalting and Multiplexed, Label-Free Ligand ScreeningJonathan Eisert, Edvaldo Vasconcelos Soares Maciel, Verena Dederer, et al.
European Journal of Medicinal Chemistry|July 23, 2024
Discovery and optimization of thiazole-based quorum sensing inhibitors as potent blockers of Pseudomonas aeruginosa pathogenicityAhmed S Abdelsamie, Mostafa M Hamed, Christian Schütz, et al.
Future Medicinal Chemistry|June 3, 2016
Discovery of the first small-molecule CsrA-RNA interaction inhibitors using biophysical screening technologiesChristine K Maurer, Martina Fruth, Martin Empting, et al.
Pageof 8